Leading the revolution in vaccine technology

Renowned scientists and entrepreneurs unite to create a unique platform for rapid development of highly versatile and efficient vaccines.

Learn More
Covid-19 Vaccine Laboratory

About us

LinKinVax is a French biotechnology startup that focuses on speeding up vaccine development by bringing together basic science and industrial processes.

Learn More

RESEARCH & DEVELOPMENT

The discovery of dendritic cells’ role in adaptative immunity system lead to a Nobel Prize in 2011.
Ten years of research later, 3 vaccines are entering clinical trial in 2022/2023. 

+
+

Press releases

LinKinVax introduces its Scientific Advisory
Board with the appointment of three leading
experts in immunology and epidemiology

See press release

LinKinVax welcomes interim results of the ANRS
VRI06 Phase I trial evaluating a novel HIV vaccine

See press release
see more

NEWS

April 24, 2023

UNE PLATEFORME VACCINALE DE CLASSE MONDIALE

PDF LINK
April 11, 2023

Le Figaro – Vaccin contre le VIH : des résultats précoces encourageants en France

CLICK HERE
April 11, 2023

TF1 : Essais cliniques contre le VIH au journal de 13h

CLICK HERE
March 14, 2023

Interview pour La Jaune et la Rouge – Mars 2023

CLICK HERE
February 7, 2023

Vaccin contre le VIH : pourquoi on échoue depuis 40 ans ? (science-et-vie.com)

CLICK HERE
February 7, 2023

Vaccin contre le Sida : “Le VIH est si compliqué qu’il fallait réfléchir autrement” (Pr Yves Lévy) – Bing video

CLICK HERE
see more

Interested in our project?

CONTACT US